Citation Impact
Citing Papers
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
2018 StandoutNobel
HIV evolution and diversity in ART-treated patients
2018
A new taxonomy for describing and defining adherence to medications
2012 Standout
New insights into T cell biology and T cell‐directed therapy for autoimmunity, inflammation, and immunosuppression
2010
Steady‐state pharmacokinetics of once‐daily fosamprenavir/ritonavir and atazanavir/ritonavir alone and in combination with 20 mg omeprazole in healthy volunteers*
2007
Factors Associated with the Emergence of K65R in Patients with HIV‐1 Infection Treated with Combination Antiretroviral Therapy Containing Tenofovir
2008
A structural equation modeling approach to the concepts of adherence and readiness in antiretroviral treatment
2007
HIV-1 Integrase Inhibitor Resistance and Its Clinical Implications
2011
Early Immunologic Failure is Associated With Early Mortality Among Advanced HIV–Infected Adults Initiating Antiretroviral Therapy With Active Tuberculosis
2013 StandoutNobel
Computer-Based Intervention in HIV Clinical Care Setting Improves Antiretroviral Adherence: The LifeWindows Project
2011
Clinical Pharmacokinetic and Pharmacodynamic Profile of the HIV Integrase Inhibitor Elvitegravir
2011
Management of spontaneous pneumothorax: British Thoracic Society pleural disease guideline 2010
2010 Standout
Management of Trichomonas vaginalis in women with suspected metronidazole hypersensitivity
2008
Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine
2009
CD4+ Cell Count 6 Years after Commencement of Highly Active Antiretroviral Therapy in Persons with Sustained Virologic Suppression
2007
A computational approach for predicting off-target toxicity of antiviral ribonucleoside analogues to mitochondrial RNA polymerase
2018 StandoutNobel
Manifestations and management of lymphogranuloma venereum
2008
Minority Quasispecies of Drug‐Resistant HIV‐1 That Lead to Early Therapy Failure in Treatment‐Naive and ‐Adherent Patients
2008
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
HIV as a chronic disease
2009
V3 Loop Sequence Space Analysis Suggests Different Evolutionary Patterns of CCR5- and CXCR4-Tropic HIV
2009
The applications of pharmacogenetics to prescribing: what is currently practicable?
2009
Recalcitrant Trichomonas Vaginalis Infections Successfully Treated With Vaginal Acidification
2008
Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV
2008
Screening for HIV: Systematic Review to Update the 2005 U.S. Preventive Services Task Force Recommendation
2012
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Incomplete Immune Recovery in HIV Infection: Mechanisms, Relevance for Clinical Care, and Possible Solutions
2012
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Harnessing Nature’s Insight: Design of Aspartyl Protease Inhibitors from Treatment of Drug-Resistant HIV to Alzheimer’s Disease
2009
Interventions for enhancing medication adherence
2014 Standout
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
2011 Standout
Works of Laura Waters being referenced
A comparison of the CD4 response to antiretroviral regimens in patients commencing therapy with low CD4 counts
2004
The Impact of HIV Tropism on Decreases in CD4 Cell Count, Clinical Progression, and Subsequent Response to a First Antiretroviral Therapy Regimen
2008
Why do patients fail HIV therapy?
2007
Impact of Different Low-Dose Ritonavir Regimens on Lipids, CD36, and Adipophilin Expression
2008
Long-term complications of antiretroviral therapy: lipoatrophy
2007
Non-nucleoside reverse transcriptase inhibitors: a review
2007
Late HIV presentation: epidemiology, clinical implications and management
2011
HIV infection and subfertility
2007
8th International Congress on Drug Therapy in HIV Infection
2007
Recalcitrant Trichomonas vaginalis infection – a case series
2005
Abacavir Plasma Pharmacokinetics in the Absence and Presence of Atazanavir/Ritonavir or Lopinavir/Ritonavir and Vice Versa in HIV-Infected Patients
2007
Tenofovir and didanosine: a dangerous liaison.
2005
Prospective HLA-B*5701 screening and abacavir hypersensitivity: a single centre experience
2007